Wingtech says Nexperia China unit now fully independent of Dutch HQ
Synopsis
Key Takeaways
Wingtech Technology has declared that Nexperia China now operates as a fully self-sufficient entity, with its core management, research and development, and production teams entirely based on the Chinese mainland — a move designed to shield the local business as the parent company battles to reassert control over the Netherlands-based chipmaker Nexperia.
What was announced
Wingtech chairwoman Ruby Yang Mu said on Friday, 29 May 2026, that Nexperia China's management, R&D, and manufacturing teams were now fully domiciled in China and held “complete operational decision-making authority.” Speaking at an annual summit hosted by JW Insights, a Chinese chip industry consultancy, Yang stated: “Today I am confident to say that Nexperia China has largely established an independent operating system.”
Why it matters
The declaration marks a significant escalation in the corporate standoff between Nexperia's Dutch headquarters and its Chinese arm. After the Dutch government intervened late last year to block Nexperia from relocating operations to China, Nexperia China declared independence from the parent, prompting Nexperia Europe to halt wafer shipments to the mainland unit. The split has effectively created two competing operational centres under the same brand.
The competitive backdrop
According to Yang, Nexperia China's production capacity and delivery capabilities are recovering steadily as the unit builds a full-stack supply chain operating on a dual model described as “China for China” and “China for global.” The strategy mirrors a broader pattern among Chinese chipmakers to localise supply chains and reduce exposure to Western regulatory pressure. “We believe that the more turbulent the times, the more crucial it is to have a solid foundation,” Yang said.
What’s next
The dispute remains unresolved, and Nexperia Europe's suspension of wafer shipments to China continues to constrain the mainland unit’s output, even as it works to build domestic alternatives. The success of Nexperia China's independence drive will hinge on whether it can fully replace European inputs through local sourcing and partnerships. Observers will be watching whether the Dutch government takes further regulatory steps or whether the two sides move toward a negotiated settlement.